These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 20546940

  • 21. Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand.
    Hirata S, Senju S, Matsuyoshi H, Fukuma D, Uemura Y, Nishimura Y.
    J Immunol; 2005 Feb 15; 174(4):1888-97. PubMed ID: 15699115
    [Abstract] [Full Text] [Related]

  • 22. CD4+ T cell expressed CD80 regulates central nervous system effector function and survival during experimental autoimmune encephalomyelitis.
    Podojil JR, Kohm AP, Miller SD.
    J Immunol; 2006 Sep 01; 177(5):2948-58. PubMed ID: 16920930
    [Abstract] [Full Text] [Related]

  • 23. Characterization of human platelet binding of recombinant T cell receptor ligand.
    Itakura A, Aslan JE, Sinha S, White-Adams TC, Patel IA, Meza-Romero R, Vandenbark AA, Burrows GG, Offner H, McCarty OJ.
    J Neuroinflammation; 2010 Nov 08; 7():75. PubMed ID: 21059245
    [Abstract] [Full Text] [Related]

  • 24. Targeting DEC-205-DCIR2+ dendritic cells promotes immunological tolerance in proteolipid protein-induced experimental autoimmune encephalomyelitis.
    Tabansky I, Keskin DB, Watts D, Petzold C, Funaro M, Sands W, Wright P, Yunis EJ, Najjar S, Diamond B, Cao Y, Mooney D, Kretschmer K, Stern JNH.
    Mol Med; 2018 May 03; 24(1):17. PubMed ID: 30134798
    [Abstract] [Full Text] [Related]

  • 25. Priming of myelin-specific T cells in the absence of dendritic cells results in accelerated development of Experimental Autoimmune Encephalomyelitis.
    Luu T, Cheung JF, Baccon J, Waldner H.
    PLoS One; 2021 May 03; 16(4):e0250340. PubMed ID: 33891644
    [Abstract] [Full Text] [Related]

  • 26. Antigen-specific suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor.
    Kobayashi N, Kobayashi H, Gu L, Malefyt T, Siahaan TJ.
    J Pharmacol Exp Ther; 2007 Aug 03; 322(2):879-86. PubMed ID: 17522343
    [Abstract] [Full Text] [Related]

  • 27. Promoting tolerance to proteolipid protein-induced experimental autoimmune encephalomyelitis through targeting dendritic cells.
    Stern JN, Keskin DB, Kato Z, Waldner H, Schallenberg S, Anderson A, von Boehmer H, Kretschmer K, Strominger JL.
    Proc Natl Acad Sci U S A; 2010 Oct 05; 107(40):17280-5. PubMed ID: 20855626
    [Abstract] [Full Text] [Related]

  • 28. A Tolerogenic Artificial APC Durably Ameliorates Experimental Autoimmune Encephalomyelitis by Directly and Selectively Modulating Myelin Peptide-Autoreactive CD4+ and CD8+ T Cells.
    Wan X, Pei W, Shahzad KA, Zhang L, Song S, Jin X, Wang L, Zhao C, Shen C.
    J Immunol; 2018 Aug 15; 201(4):1194-1210. PubMed ID: 29987163
    [Abstract] [Full Text] [Related]

  • 29. IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis.
    Young DA, Lowe LD, Booth SS, Whitters MJ, Nicholson L, Kuchroo VK, Collins M.
    J Immunol; 2000 Apr 01; 164(7):3563-72. PubMed ID: 10725711
    [Abstract] [Full Text] [Related]

  • 30. Treatment of relapsing autoimmune encephalomyelitis with T cell receptor V beta-specific antibodies when proteolipid protein is the autoantigen.
    Whitham RH, Wingett D, Wineman J, Mass M, Wegmann K, Vandenbark A, Offner H.
    J Neurosci Res; 1996 Jul 15; 45(2):104-16. PubMed ID: 8843028
    [Abstract] [Full Text] [Related]

  • 31. Involvement of regulatory T cells in the experimental autoimmune encephalomyelitis-preventive effect of dendritic cells expressing myelin oligodendrocyte glycoprotein plus TRAIL.
    Hirata S, Matsuyoshi H, Fukuma D, Kurisaki A, Uemura Y, Nishimura Y, Senju S.
    J Immunol; 2007 Jan 15; 178(2):918-25. PubMed ID: 17202353
    [Abstract] [Full Text] [Related]

  • 32. Treatment of relapsing experimental autoimmune encephalomyelitis with T cell receptor peptides.
    Whitham RH, Kotzin BL, Buenafe AC, Weinberg AD, Jones RE, Hashim GA, Hoy CM, Vandenbark AA, Offner H.
    J Neurosci Res; 1993 Jun 01; 35(2):115-28. PubMed ID: 7686583
    [Abstract] [Full Text] [Related]

  • 33. An epitope from Acanthamoeba castellanii that cross-react with proteolipid protein 139-151-reactive T cells induces autoimmune encephalomyelitis in SJL mice.
    Massilamany C, Steffen D, Reddy J.
    J Neuroimmunol; 2010 Feb 26; 219(1-2):17-24. PubMed ID: 20005578
    [Abstract] [Full Text] [Related]

  • 34. Peroxisome Proliferator-Activated Receptor-δ Acts within Peripheral Myeloid Cells to Limit Th Cell Priming during Experimental Autoimmune Encephalomyelitis.
    Drohomyrecky PC, Doroshenko ER, Akkermann R, Moshkova M, Yi TJ, Zhao FL, Ahn JJ, McGaha TL, Pahan K, Dunn SE.
    J Immunol; 2019 Nov 15; 203(10):2588-2601. PubMed ID: 31578267
    [Abstract] [Full Text] [Related]

  • 35. The DC-HIL/syndecan-4 pathway regulates autoimmune responses through myeloid-derived suppressor cells.
    Chung JS, Tamura K, Akiyoshi H, Cruz PD, Ariizumi K.
    J Immunol; 2014 Mar 15; 192(6):2576-84. PubMed ID: 24516197
    [Abstract] [Full Text] [Related]

  • 36. CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis.
    Zhu B, Bando Y, Xiao S, Yang K, Anderson AC, Kuchroo VK, Khoury SJ.
    J Immunol; 2007 Oct 15; 179(8):5228-37. PubMed ID: 17911608
    [Abstract] [Full Text] [Related]

  • 37. Role of IL-12 receptor beta 1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis.
    Zhang GX, Yu S, Gran B, Li J, Siglienti I, Chen X, Calida D, Ventura E, Kamoun M, Rostami A.
    J Immunol; 2003 Nov 01; 171(9):4485-92. PubMed ID: 14568921
    [Abstract] [Full Text] [Related]

  • 38. TGF-beta-induced myelin peptide-specific regulatory T cells mediate antigen-specific suppression of induction of experimental autoimmune encephalomyelitis.
    Zhang H, Podojil JR, Chang J, Luo X, Miller SD.
    J Immunol; 2010 Jun 15; 184(12):6629-36. PubMed ID: 20483764
    [Abstract] [Full Text] [Related]

  • 39. Tim-1 stimulation of dendritic cells regulates the balance between effector and regulatory T cells.
    Xiao S, Zhu B, Jin H, Zhu C, Umetsu DT, DeKruyff RH, Kuchroo VK.
    Eur J Immunol; 2011 Jun 15; 41(6):1539-49. PubMed ID: 21469101
    [Abstract] [Full Text] [Related]

  • 40. Monomeric DR2/MOG-35-55 recombinant TCR ligand treats relapses of experimental encephalomyelitis in DR2 transgenic mice.
    Link JM, Rich CM, Korat M, Burrows GG, Offner H, Vandenbark AA.
    Clin Immunol; 2007 Apr 15; 123(1):95-104. PubMed ID: 17257899
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.